The Power of an Omnichannel Network: Insights from HLTH
During my recent session at HLTH, I was given the opportunity to speak on the importance of a strong omnichannel strategy and how it can improve HCP engagement.
Conversations that Convert
Explore the results of OptimizeRx 2024 physician survey on pharma marketing perception and impact – including the untapped opportunity of HCP and DTC marketing alignment.
Conversations that Convert
Explore the results of OptimizeRx 2024 physician survey on pharma marketing perception and impact – including the untapped opportunity of HCP and DTC marketing alignment.
Ideas, Insights, and Inspiration for Modern Healthcare Marketers
Explore our full library of resources developed by healthcare industry leaders aimed to spark actionable ideas.
Let's Talk
Want patients and providers talking about your brand? Talk to us first.
Insights from HLTH: Promoting Medication Affordability with AI and RWD
During my recent session at HLTH, I had the great opportunity to share a case study on how AI and real world data (RWD) increased medication affordability for patients by creating a more informed and empowered healthcare community. With...
Secrets of the Data Ninjas: Takeaways from Digital Pharma East
Real-World Data (RWD) has become an essential element of pharmaceutical marketing, but as an industry, we are far from utilizing its full potential. During my recent session at Digital Pharma East, I had the great opportunity to share the...
Hub and Specialty Pharmacy Models West Takeaways: Overcoming Prior Authorization Hurdles with Technology
Overcoming Disadvantaged Access Positions with Digital Tools at the Point-of-Care In almost every therapy area, utilization management, prior authorizations, and step therapy requirements increased between 2014 and 2020. For example, in...
Increased Osteoarthritis Brand Awareness and Prescribing Through Copay Promotion
There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall economic burden of almost $140 Billion annually.
Addressing Medication Affordability in Vulnerable Patients During COVID-19
Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the estimated 40% of Americans living with a medical-related ailment that...
Improving Access to Mental Healthcare with OptimizeRx Financial Messaging
The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a steady increase every year since 2011.
Overcoming Challenges Related to Multiple Sclerosis Treatment: The Complete Picture
Key Themes and Takeways from Our Multiple Sclerosis Series In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas that can impact their health outcomes: Delayed diagnosis or...
Overcoming Challenges Related to Multiple Sclerosis Treatment: Patient Adherence
Part Three of Our Multiple Sclerosis Series In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness in order to reduce occurrences of delayed or incorrect diagnosis...
Overcoming Challenges Related to Multiple Sclerosis Treatment: Initiating Treatment
Part Two of Our Multiple Sclerosis Series In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is awareness. A lack of awareness on the part of primary care physicians,...
Omnichannel Strategy Insights from Digital Pharma East 2021
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true omnichannel experience for HCPs. That’s why I was excited to present...
Access and Affordability Trends in Rare and Orphan Disease
.png?width=50&name=MicrosoftTeams-image%20(5).png)
An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone1. Rare diseases are classified as any disease that affects less than 200,000 people1. Orphan diseases, including rare diseases, are...